These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30893872)

  • 41. Hyperphosphorylation of tau and protein phosphatases in Alzheimer disease.
    Liu F; Liang Z; Gong CX
    Panminerva Med; 2006 Jun; 48(2):97-108. PubMed ID: 16953147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pinning down phosphorylated tau and tauopathies.
    Lim J; Lu KP
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):311-22. PubMed ID: 15615648
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta.
    Reynolds CH; Betts JC; Blackstock WP; Nebreda AR; Anderton BH
    J Neurochem; 2000 Apr; 74(4):1587-95. PubMed ID: 10737616
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites.
    Hoffmann R; Lee VM; Leight S; Varga I; Otvos L
    Biochemistry; 1997 Jul; 36(26):8114-24. PubMed ID: 9201960
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein.
    Porzig R; Singer D; Hoffmann R
    Biochem Biophys Res Commun; 2007 Jun; 358(2):644-9. PubMed ID: 17499212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer's disease-related tau pathology.
    Sepulveda-Diaz JE; Alavi Naini SM; Huynh MB; Ouidja MO; Yanicostas C; Chantepie S; Villares J; Lamari F; Jospin E; van Kuppevelt TH; Mensah-Nyagan AG; Raisman-Vozari R; Soussi-Yanicostas N; Papy-Garcia D
    Brain; 2015 May; 138(Pt 5):1339-54. PubMed ID: 25842390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early phosphorylation of tau in Alzheimer's disease occurs at Ser-202 and is preferentially located within neurites.
    Su JH; Cummings BJ; Cotman CW
    Neuroreport; 1994 Nov; 5(17):2358-62. PubMed ID: 7533559
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Critical residues involved in tau binding to fyn: implications for tau phosphorylation in Alzheimer's disease.
    Lau DH; Hogseth M; Phillips EC; O'Neill MJ; Pooler AM; Noble W; Hanger DP
    Acta Neuropathol Commun; 2016 May; 4(1):49. PubMed ID: 27193083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tau Abnormalities and the Potential Therapy in Alzheimer's Disease.
    Almansoub HAMM; Tang H; Wu Y; Wang DQ; Mahaman YAR; Wei N; Almansob YAM; He W; Liu D
    J Alzheimers Dis; 2019; 67(1):13-33. PubMed ID: 30507581
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alzheimer disease hyperphosphorylated tau aggregates hydrophobically.
    Ruben GC; Ciardelli TL; Grundke-Iqbal I; Iqbal K
    Synapse; 1997 Nov; 27(3):208-29. PubMed ID: 9329157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Research progress of abnormal phosphorylation of microtubule-associated tau protein and of the targeted inhibition of the phosphorylation].
    Zhou F; Chen S; Sun X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2012 Aug; 29(4):788-92. PubMed ID: 23016437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Probable participation of 14-3-3 in tau protein oligomerization and aggregation.
    Sluchanko NN; Gusev NB
    J Alzheimers Dis; 2011; 27(3):467-76. PubMed ID: 21876254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein.
    Goedert M; Jakes R; Crowther RA; Cohen P; Vanmechelen E; Vandermeeren M; Cras P
    Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):871-7. PubMed ID: 7519852
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phosphorylation of Tau R2 Repeat Destabilizes Its Binding to Microtubules: A Molecular Dynamics Simulation Study.
    Man VH; He X; Gao J; Wang J
    ACS Chem Neurosci; 2023 Feb; 14(3):458-467. PubMed ID: 36669127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current and novel therapeutic molecules and targets in Alzheimer's disease.
    Kumar A; Nisha CM; Silakari C; Sharma I; Anusha K; Gupta N; Nair P; Tripathi T; Kumar A
    J Formos Med Assoc; 2016 Jan; 115(1):3-10. PubMed ID: 26220908
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tau phosphorylation and aggregation in Alzheimer's disease pathology.
    Avila J
    FEBS Lett; 2006 May; 580(12):2922-7. PubMed ID: 16529745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathological Alterations of Tau in Alzheimer's Disease and 3xTg-AD Mouse Brains.
    Li L; Jiang Y; Hu W; Tung YC; Dai C; Chu D; Gong CX; Iqbal K; Liu F
    Mol Neurobiol; 2019 Sep; 56(9):6168-6183. PubMed ID: 30734228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of glycosylation in hyperphosphorylation of tau in Alzheimer's disease.
    Liu F; Zaidi T; Iqbal K; Grundke-Iqbal I; Merkle RK; Gong CX
    FEBS Lett; 2002 Feb; 512(1-3):101-6. PubMed ID: 11852060
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Absence of abnormal hyperphosphorylation of tau in intracellular tangles in Alzheimer's disease.
    Bondareff W; Harrington CR; Wischik CM; Hauser DL; Roth M
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):657-63. PubMed ID: 7666054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.